A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
for Alzheimer Disease
52 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 55+
Code: NCT07602582·Phase 3·Recruiting·Listed May 2026
Clinical research site in Shavano Park, Texas
Part of Consano Clinical Research
As of July 2026, 15 paid clinical trials are recruiting at Consano Clinical Research, LLC in Shavano Park, Texas. Active studies at this site cover conditions such as Obesity, Diabetes Mellitus, Type 2 and Overweight. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Paid clinical trials in Shavano Park, TX · Texas clinical trials